Zebrafish as model organisms for studying drug‐induced liver injury

British Journal of Clinical Pharmacology - Tập 78 Số 6 - Trang 1217-1227 - 2014
A. D. Bastiaan Vliegenthart1, Carl S. Tucker2, Jorge del Pozo3, James W. Dear1
1Pharmacology, Toxicology and Therapeutics, British Heart Foundation, Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, EH16 4TJ UK
2Biomedical Research Resources, The College of Medicine and Veterinary Medicine, The University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ UK
3Easter Bush Pathology, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Campus, Roslin, Midlothian, EH25 9RG UK

Tóm tắt

Drug‐induced liver injury (DILI) is a major challenge in clinical medicine and drug development. New models are needed for predicting which potential therapeutic compounds will cause DILI in humans, and new markers and mediators of DILI still need to be identified. This review highlights the strengths and weaknesses of using zebrafish as a high‐throughput in vivo model for studying DILI. Although the zebrafish liver architecture is different from that of the mammalian liver, the main physiological processes remain similar. Zebrafish metabolize drugs using similar pathways to those in humans; they possess a wide range of cytochrome P450 enzymes that enable metabolic reactions including hydroxylation, conjugation, oxidation, demethylation and de‐ethylation. Following exposure to a range of hepatotoxic drugs, the zebrafish liver develops histological patterns of injury comparable to those of mammalian liver, and biomarkers for liver injury can be quantified in the zebrafish circulation. The zebrafish immune system is similar to that of mammals, but the zebrafish inflammatory response to DILI is not yet defined. In order to quantify DILI in zebrafish, a wide variety of methods can be used, including visual assessment, quantification of serum enzymes and experimental serum biomarkers and scoring of histopathology. With further development, the zebrafish may be a model that complements rodents and may have value for the discovery of new disease pathways and translational biomarkers.

Từ khóa


Tài liệu tham khảo

10.1080/15563650701754763

10.1136/bmj.f403

10.1172/JCI110853

10.3109/15563650.2012.659252

TempleRJ.Hepatotoxicity through the years: impact on the FDA.2001. Available athttp://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/ucm122149.pdf(last accessed March 2014).

Farrell GC, 2002, Drugs and the liver updated, 2002, Semin Liver Dis, 22, 109

10.1056/NEJMc060733

10.1038/nrg2091

10.1016/j.drudis.2008.03.002

10.1038/bjp.2008.249

10.1016/S0300-483X(00)00316-4

10.1016/S0928-0987(01)00135-X

10.1016/j.tiv.2005.01.003

10.1124/dmd.105.006759

10.1093/toxsci/kfg064

10.1007/s00204-006-0091-3

Chen JN, 1996, Mutations affecting the cardiovascular system and other internal organs in zebrafish, Development (Cambridge, England), 123, 293, 10.1242/dev.123.1.293

10.1038/nature12111

10.1152/ajpregu.00589.2001

10.1172/JCI60434

10.1242/dmm.011346

10.1177/0192623311409597

10.1016/S1673-8527(08)60121-6

10.1006/dbio.2000.9995

10.1002/hep.20691

10.1242/dev.01411

10.1186/1471-2164-11-643

10.1038/nrc2015

10.1111/j.1749-6632.1971.tb46896.x

10.1038/nrd3408

10.1016/0041-008X(69)90032-5

10.2165/11599230-000000000-00000

10.1016/S0378-4347(97)00239-9

10.1080/03602530701836662

10.3109/00498254.2012.684410

10.1073/pnas.81.5.1327

10.1080/00498250802512830

10.1016/j.tiv.2008.02.001

10.1177/1087057112447305

10.3109/00498254.2010.493960

Meuldermans W, 1988, Excretion and biotransformation of cisapride in dogs and humans after oral administration, Drug Metab Dispos, 16, 403

Eichelbaum M, 1979, The metabolism of DL‐[14C]verapamil in man, Drug Metab Dispos, 7, 145

10.3109/03602532.2012.746363

10.1038/nm.3104

10.1016/j.cca.2005.04.003

10.1210/mend.16.5.0828

10.1016/j.taap.2004.10.019

10.1007/BF02977789

10.3109/10408449709021615

10.1016/0165-6147(92)90076-I

10.1002/hep.26115

10.1111/j.1478-3231.2011.02501.x

10.3109/03602532.2011.645579

10.1038/nrd2423

10.1146/annurev.pharmtox.47.120505.105150

10.1038/ng.379

10.1016/j.jhep.2010.05.033

10.1073/pnas.0307067101

10.1016/S0140-6736(02)07873-X

10.1046/j.1365-2141.2003.04682.x

10.1002/eji.201343557

10.1016/j.tox.2009.04.013

10.3109/03602532.2011.645578

10.1016/j.vascn.2012.10.003

10.1371/journal.pone.0091874

10.1073/pnas.1008209107

10.1016/0147-6513(90)90036-5

10.1007/s11373-005-9055-5

10.1002/hep.22667

Murtha JM, 2003, Hematologic and serum biochemical values for zebrafish (Danio rerio), Comp Med, 53, 37

10.1002/hep.24538

10.1089/zeb.2013.0912

10.1016/j.celrep.2013.12.007

10.1038/nchembio732

10.1016/j.vascn.2008.05.130

10.1002/bies.10326

Doshna C, 2009, Multi‐phase analysis of uptake and toxicity in Zebrafish: relationship to compound physical‐chemical properties, Toxicol Sci, 108, 78

10.1016/j.reprotox.2011.06.119

10.1016/j.ddmod.2012.02.005

10.1021/pr3009226

10.1046/j.1365-2141.1999.01763.x

10.1089/zeb.2009.0640

Pedroso GL, 2012, Blood collection for biochemical analysis in adult zebrafish, J Vis Exp, 63, e3865

10.1089/zeb.2012.0862

10.1080/07420520500180231

Thông tin
Thông tin xuất bản

British Journal of Clinical Pharmacology

Tập 78 Số 6

1217-1227

Thông tin tác giả